<i>M. tuberculosis</i> ESX-3 EccD3 domain.

<p>(a) EccD3 N-terminal and EccD3 C-terminal interactions with the nine drugs having Z-score values less than -1. D, Molecular interactions between EccD3 interface residues and (b) selamectin, (c) moxidectin, and (d) rifalazil in 2D diagram. Ligplot was used for 2D map.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Ana Laura Granados-Tristán (21144439) (author)
مؤلفون آخرون:	Mauricio Carrillo-Tripp (3183507) (author), Carlos Eduardo Hernández-Luna (21144442) (author), Aldo Herrera-Rodulfo (21144445) (author), Laura Adiene González-Escalante (8890166) (author), Ana Leticia Arriaga-Guerrero (8890154) (author), Beatriz Silva-Ramírez (8890169) (author), Brenda Leticia Escobedo-Guajardo (18809428) (author), Roberto Mercado-Hernández (8890172) (author), Mario Bermúdez de León (21144448) (author), Katia Peñuelas-Urquides (11639896) (author)
منشور في:	2025
الموضوعات:	Biophysics Biochemistry Medicine Microbiology Molecular Biology Pharmacology Biotechnology Cancer Infectious Diseases Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified inhibited using crispri 3 secretion system favorable δg values tertiary protein structures new therapeutic targets eccd3 dimer interfaces div >< p mycolicibacterium smegmatis </ mycobacterium tuberculosis </ ivermectin susceptibility increased mycobacterium susceptibility smegmatis </ tuberculosis </ new drugs molecular structures ivermectin targets eccd3 protein eccd3 increased best δg resistant tuberculosis vitro </ silico </ eccd3 </ zinc homeostasis quaternary interface prospective drugs predicted based preclinical studies ivermectin action compensatory mechanisms
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

<i>M. tuberculosis</i> ESX-3 EccD3 domain.

مواد مشابهة